CoChat

The role of iron in cell cycle progression and the proliferation of neoplastic cells

Le, N · 2002 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.

Abstract

Iron (Fe) is an obligate requirement for life and it is well known that Fe depletion leads to G(1)/S arrest and apoptosis. These facts, together with studies showing that Fe chelators can inhibit the growth of aggressive tumours such as neuroblastoma, suggest that Fe-deprivation may be an important therapeutic strategy. To optimise the anti-proliferative effects of Fe chelators, the role of Fe in cell cycle control requires intense investigation. For many years, Fe chelators were known to prevent the activity of the R2 subunit of ribonucleotide reductase (RR) that catalyzes the conversion of ribonucleotides into deoxyribonucleotides (dNTPs) for DNA synthesis. In addition, Fe depletion may also inhibit the newly identified p53-inducible form of this molecule called p53R2. This protein has the same Fe-binding sites as found in R2, and its activity is thought to supply dNTPs for the critical process of DNA repair. Iron chelation also causes hypophosphorylation of the retinoblastoma protein (pRb) and decreases the expression of cyclins A, B and D, which are vital for cell cycle progression. Other regulatory molecules whose expression is affected by Fe depletion include p53 and hypoxia inducible factor-1alpha (HIF-1alpha). The levels of p53 increase following Fe chelation via the ability of HIF-1alpha to bind and stabilize p53. The activity of HIF-1alpha is controlled by an Fe-dependent enzyme known as HIF-alpha prolyl hydroxylase (PH). Chelation of Fe from this enzyme inhibits it…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0304-419x(02)00068-9

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 164 references

Cited by

See all 505

Metadata

Authors
Le, N.
Affiliations
The Heart Research Institute (AU)
Corresponding author
Le, N
ORCID
Le, N
Venue
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Publisher
Elsevier BV
Published
2002-10-02
Volume
1603
Issue
1
Pages
31-46
ISSN
0304-419X (ISSN-L)
OpenAlex
W2090055655
Cited by
453
References
164
Citations by year
2026: 3 · 2025: 6 · 2024: 9 · 2023: 21 · 2022: 17 · 2021: 18 · 2020: 17 · 2019: 20 · 2018: 18 · 2017: 23 · 2016: 22 · 2015: 18 · 2014: 15 · 2013: 27 · 2012: 26
FWCI
9.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords
iron chelation, iron depletion, cell cycle progression, p53R2, p53, retinoblastoma protein, cyclins, hypoxia-inducible factor-1α, p21, MDM2
MeSH terms
Amino Acid Sequence, Animals, Antineoplastic Agents, Cell Cycle, DNA Damage, DNA-Binding Proteins, Humans, Iron, Iron Chelating Agents, Molecular Sequence Data, Pyridines, Ribonucleotide Reductases, Thiosemicarbazones, Transcription Factors, Gene Expression Regulation, Neoplastic, Genes, myc, Drug Delivery Systems, RNA-Binding Proteins, Clinical Trials, Phase II as Topic, Cell Cycle Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of iron in cell cycle progression and the proliferation of neoplastic cells. https://app.cochat.ai/papers/10.1016/s0304-419x(02)00068-9
The paper
Le, N. (2002). The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/s0304-419x(02)00068-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.